BioWorld Science delivers discovery and preclinical research news to support crucial drug R&D decisions at the earliest stages every business day. On this site, you’ll find that the lead article is freely available. The rest of the daily headlines link back to the legacy site. If you’re a subscriber, click on any headline and you’ll be taken back to the original site, which is still active.
Full migration coming soon
This new microsite includes daily headlines as we work to transition BioWorld Science fully to this website.
Every business day, BioWorld Science selects the latest, most important drug discovery and development news, places it in context, and presents it online and as email alerts in a clear, concise format that makes it easy to discover the important facts at a glance.
BioWorld Science coverage includes:
Especially for the research team
Researchers who need more technical details will find that BioWorld Science delivers competitive scientific intelligence about novel compounds and those in development across all therapy areas drawn from multiple information sources. Direct links lead to biomarker records and additional information in Cortellis Drug Discovery Intelligence.
Monitor the kind of news delivered in BioWorld Science. To subscribe and access the full content every business day, click here to contact customer service.